Nerveli Inc. filed a Form D with the Securities and Exchange Commission on 2025-09-16.
Nerveli Inc. filed a Form D notice of an exempt securities offering with the SEC on September 16, 2025. The filing reports $430K sold. Its industry group is Other Health Care. It names Leon Jacobson (Executive Officer, Director), Ted Price (Director), Amol Patwardhan (Director) (SEC Form D, September 16, 2025).
125 companies raised this week.
Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.
| Andersen Aggregator LLC | $1.9B | Business services |
| AT Umbrella LLC | $1.9B | Business services |
| Legora, Inc. | $221M | AI and software |
| MD INVESTMENT LLC | $169M | Business services |
| Serval Inc. | $149M | AI and software |
Is this your company?
Sell to companies like Nerveli Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-09-16 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Nerveli Inc.
Free to see. No signup.
More on the people and the money behind Nerveli Inc., from the filings we hold.
Other Health Care raises by companies based in Texas, filed in September 2025, largest first.
Get an email when Nerveli Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Nerveli Inc. raises, hires or launches. No email unless you switch it on.
Watch Nerveli Inc. →Get the full cited report on Nerveli Inc.
What the filing shows about Nerveli Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Nerveli Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Nerveli Inc.'s address as 5818 Buffridge Trail, Dallas, TX 75252.
Saved here on this device in the meantime, so nothing is lost either way.
Full funding history for Nerveli Inc. →
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Nerveli Inc. is a registered filer with the SEC (CIK 2084682) and has filed since 2025-09-16. 2 filings are on record, the latest on 2026-07-14.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Nerveli Inc.'s Form D of 2025-09-16 names Leon Jacobson, Ted Price and Amol Patwardhan as its officers, directors or promoters.
Its new offerings report $600K sold across 2 offerings, as its own filings state.
Each marker is one filing. The larger marker is the filing this page is about.
Trailing twelve months. 871 filings in Other Health Care, totalled by week.
Leon Jacobson is named as Executive Officer and Director on the Form D that Nerveli Inc. filed with the SEC on 16 September 2025, one of 3 people that filing names.
Ted Price is named as Director on the Form D that Nerveli Inc. filed with the SEC on 16 September 2025, one of 3 people that filing names.
Amol Patwardhan is named as Director on the Form D that Nerveli Inc. filed with the SEC on 16 September 2025, one of 3 people that filing names.
3 people named on the filing — 1 holding an executive role and 2 as directors only.
Named as of the 2025-09-16 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Nerveli Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Nerveli Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Nerveli Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Nerveli Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Nerveli Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Nerveli Inc.. With no account yet, you sign up free and land on the result.
On these lists: Health care raises in Dallas-Fort Worth
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/nerveli-inc-form-d-25000001